A furious row has broken out between a drugs company and the NHS regulator in England over the price of a new breast cancer treatment.
Kadcyal which is manufactured by Roche Products Limited can give patients with HER2-positive breast cancer an additional six months of life, but the regulator deemed it too expensive.
ITV News correspondent Nina Nannar reports.
More top news
Largely dry night, but showers set to spread in from the west during tomorrow
Two people have died after being involved in separate lightning strikes in Wales' Brecon Beacons today.
France's Champagne and Burgundy wine regions have been granted Unesco world heritage status, as the remit for the title broadens.